Cognitive Dysfunction among HIV Positive and HIV Negative Patients with Psychosis in Uganda

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Nakasujja, Noeline ^a,b   Allebeck, Peter ^b   Agren, Hans ^c   Musisi, Seggane ^a   Katabira, Elly ^a  

^a MAKERERE UNIVERSITY   (Uganda)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COGNITION; COGNITIVE DEFECT; COLOR TRAILS 1; COLOR TRAILS 2; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MINI INTERNATIONAL NEUROPSYCHIATRIC INVENTORY PLUS; MINI MENTAL STATE EXAMINATION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROPSYCHOLOGICAL TEST; PATIENT CARE; PHYSICAL EXAMINATION; PSYCHOLOGIC TEST; PSYCHOSIS; QUESTIONNAIRE; VERBAL FLUENCY; WHO UCLA AUDITORY VERBAL LEARNING TEST;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; COGNITION DISORDERS; FEMALE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS; UGANDA; YOUNG ADULT;

EID: 84866060188     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044415     Document Type: Article

References (37)

1. Goldberg TE, Berman KF, Weinberger DR, (1995) Neuropsychology and neurophysiology of schizophrenia. Current Opinion in Psychiatry 8: 34-40.
2. Fitzgerald D, Lucas S, Redoblado MA, Winter V, Brennan J, et al. (2004) Cognitive functioning in young people with first episode psychosis: Relationship to diagnosis and clinical characteristics. Aust N Z J Psychiatry 38: 501-510.
3. Hori H, Noguchi H, Hashimoto R, Nakabayashi T, Omori M, et al. (2006) Antipsychotic medication and cognitive function in schizophrenia. Shizophr Res 86: 138-146.
4. Schmand B, Kuipers T, Van der Gaag M, Bosveld J, Bulthuis, et al, (1993) Cognitive disorders and negative symptoms as correlates of motivational deficits in psychotic patients. Psychological Medicine 24: 869-884.
5. Bora E, Yüce M, Pantelis C, (2010) Cognitive Impairment in Schizophrenia and Affective Psychoses: Implications for DSM-V Criteria and Beyond. Schizophr Bull 36: 36-42.
6. Sewell DD, Jeste DV, Atkinson JH, Heaton RH, Hesselink JR, et al. (1994) HIV associated psychosis: a study of 20 cases. Am J of Psychiatry 151: 237-242.
7. Nakimuli-Mpungu E, Musisi S, Mpungu SK, Katabira E, (2006) Primary mania versus HIV-related secondary mania in Uganda. Am J Psychiatry 163: 1349-1354; quiz 1480.
8. Starace F, Bartoli L, Aloisi M, Antinori A, Narciso P, et al. (2002) Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the NeuroICONA study. Cognitive impairment and depression in HIV/AIDS. The NeuroICONA study. Acta Psychiatr Scand 106: 20-26.
9. Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M, et al. (2006) Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology 67: 311-314.
10. Nath A, Schiess N, Venkatesan A, Rumbaugh J, Sacktor N, et al. (2008) Evolution of HIV dementia with HIV infection. International Review of Psychiatry 20: 25-31.
11. Wong MH, Robertson K, Nakasujja N, Skolasky R, Musisi S, et al. (2007) Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology 68: 350-355.
12. Robertson K, Smurzynski M, Parsons TD, Wu K, Bosch R, et al. (2007) The prevalence and incidence of neurocognitive impairment in the HAART era AIDS. 21: 1915-1921.
13. Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, et al. (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75: 2087-2096.
14. Kapiriri L, Sofaer N, Atuyambe L, Otolok-Tanga E, Norheim OF, (2009) Criteria used for selecting patients for antiretroviral therapy in Uganda: A qualitative study. Journal of AIDS and HIV Research 1: 034-043.
15. Shapshak P, Kangueane P, Fujimura RK, Commins D, Chiappelli F, et al. (2011) Editorial NeuroAIDS review. AIDS 25: 123.
16. Sheehan D, Lecrubier Y, Sheehan K, Amorim P, Janavs J, et al. (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59: 22-33.
17. Young R, Biggs J, Ziegler V, Meyer D, (1978) A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry 133: 429-435.
18. Overall J, Gorham D, (1962) The brief psychiatric rating scale. Psychological Reports 10: 799-812.
19. Kroenke K, Spitzer RL, Williams JB, (2001) The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med 16: 606-613.
20. Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, et al. (2005) The International HIV Dementia Scale: a new rapid screening test for HIV dementia. Aids 19: 1367-1374.
21. Robertson KR, Nakasujja N, Wong M, Musisi S, Katabira E, et al. (2007) Pattern of neuropsychological performance among HIV positive patients in Uganda. BMC Neurol 7: 8.
22. Folstein MF, Folstein SE, McHugh PR, (1975) "Mini-Mental State": A Practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12: 189-198.
23. Hill K, Reilly J, Harris M, Rosen C, Marvin R,et al. (2009) A comparison of neuropsychological dysfunction in first-episode psychosis patients with unipolar depression, bipolar disorder, and schizophrenia. Schizophrenia Research 113: 167-175.
24. Maling S, Todd J, Van der Paal L, Grosskurth H, Kinyanda E, (2011) HIV-1 seroprevalence and risk factors for HIV infection among first-time psychiatric admissions in Uganda. AIDS Care 23: 171-178.
25. Iacono W, Beiser M, (1992) Are males more likely than females to develop schizophrenia? Am J Psychiatry 149: 1070-1074.
26. McArthur JC, (2004) HIV dementia: an evolving disease. J Neuroimmunol 157: 3-10.
27. Kipp W, Alibhai A, Saunders L, Senthilselvan A, Kaler A, et al. (2010) Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda. AIDS Care-Psychological and socio-medical aspects of AIDS/HIV 22: 271-278.
28. Baran H, Hainfellner JA, Kepplinger B, Mazal PR, Schmid H, et al. (2000) Kynurenic acid metabolism in the brain of HIV-1 infected patients. J Neural Transm 107: 1127-1138.
29. Atlas A, Gisslen M, Nordin C, Lindstrom L, Schweiler L, (2007) Acute psychotic symptoms in HIV-1 infected patients are associated with increased levels of kynurenic acid in cerebrospinal fluid. Brain Behav Immun 21: 86-91.
30. el-Mallakh RS, (1992) HIV-related psychosis. J Clin Psychiatry 53: 293-294.
31. Horwah E, (2002) Psychiatric and neuropsychiatric manifestations of HIV infection. Journal of the International Association of Physicians in AIDS Care 1: S4-S15.
32. Dolder CR, Patterson TL, Jeste PT, (2004) HIV Psychosis and ageing: past, present and future. AIDS 18: 35-82.
33. Dubé B, Benoit T, Cruess DG, Evans DL, (2005) Neuropsychiatric manifestations of HIV infection and AIDS. J Psychiatry Neurosci 30: 237-246.
34. Nilsson L, Linderholm K, Engberg G, Paulson L, Blennow K, et al. (2005) Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia. Schizophr Res 80: 315-322.
35. Nakimuli-Mpungu E, Musisi S, Kiwuwa S, Katabira E, (2008) Early-Onset Versus Late-Onset HIV-Related Secondary Mania in Uganda. Psychosomatics 49: 530-534.
36. Sacktor N, Skolasky RL, Lyles RH, Esposito D, Selnes OA, et al. (2000) Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. Journal of Neurovirology 6: 84-88.
37. De Ronchi D, Faranca I, Forti P, Ravagalia G, Borderi M, et al. (2000) Development of acute psychotic disorders in HIV infection. International Journal of Psychiatry and Medicine 30: 173-183.